Diabetes mellitus and unstable coronary artery disease: improved clinical outcome of coronary artery stenting in an era of glycoprotein IIb/IIIa inhibitors and lipid-lowering therapy

In Brief Objective The short- and long-term clinical outcomes of coronary artery stenting in diabetic patients with unstable coronary artery disease were assessed and compared with a cohort of non-diabetic patients in the context of platelet glycoprotein IIb/IIIa inhibitors and lipid-lowering therapy. Methods The study population comprised 252 consecutive patients with unstable angina who underwent coronary artery stenting; of these 46 were diabetic and 206 were non-diabetic. In-hospital results and clinical outcome during follow-up (24±13 months, range 7–56 months) were obtained in all patients without major in-hospital complications. Survival curves and multivariate models for any late clinical event were reported. Results A high clinical success rate and no difference in in-hospital complications between the two groups of patients were observed. Complete revascularization rate was similar in diabetic and non-diabetic patients (48% compared with 52%). A greater proportion of diabetic than non-diabetic patients received IIb/IIIa inhibitors during the procedure and lipid-lowering drugs at hospital discharge (87% compared with 46%, P=0.001 and 83% compared with 61%, P=0.006 respectively). At 2-year clinical follow-up, the incidences of death and myocardial infarction were similar in both groups; the need for any revascularization was only slightly higher in diabetic patients (P=NS). Incomplete revascularization and multi-vessel disease were independent predictors of any revascularization. Conclusions Coronary artery stenting combined with glycoprotein IIb/IIIa inhibitor infusion and long-term lipid-lowering therapy is an effective therapeutic strategy in diabetic patients with unstable coronary artery disease and is associated with good short- and long-term results, comparable to those observed in non-diabetic patients. We assessed the short and long-term clinical outcome of coronary artery stenting in 46 diabetic patients with unstable coronary artery disease and compared them with a cohort of 206 non-diabetic patients in the era of platelet glycoprotein IIb/IIIa inhibitors and lipid-lowering therapy. In hospital results and clinical outcome during follow-up (24±13 months, range 7–56 months) were similar in both groups; the need of any revascularization was only slightly higher in diabetic patients (P=NS). Incomplete revascularization and multi-vessel disease were independent predictors of any revascularization. Therefore,coronary artery stenting combined with glycoprotein IIb/IIIa inhibitors infusion and long-term lipid-lowering therapy is an effective therapeutic strategy in diabetics with unstable coronary artery disease and is associated with good short-and long-term results, comparable to those observed in non-diabetic patients.